Ashiq Mubarack

Stock Analyst at Citigroup

(0.91)

# 3,680

Out of 4,846 analysts

3

Total ratings

66.67%

Success rate

-17.35%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$0.37	+1,237.26%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$2.93	+173.04%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $0.37

Upside: +1,237.26%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $2.93

Upside: +173.04%